Both quantitative real-time PCR (qRT-PCR) and enzyme-linked immunosorbent assays (ELISA) indicated that plasma FKBP5 expression is higher in AIS patients than healthy individuals (Figures 1A,B). Here, FKBP5 is linked to androgen insensitivity syndrome.